95 related articles for article (PubMed ID: 8740582)
1. The carboxy-terminal cross-linked telopeptide of type I collagen (ICTP) is a potential serum marker of ongoing liver fibrosis.
Ricard-Blum S; Chossegros P; Guerret S; Trepo C; Grimaud JA; Chevallier M
Clin Chim Acta; 1996 Apr; 248(2):187-95. PubMed ID: 8740582
[TBL] [Abstract][Full Text] [Related]
2. Serum carboxy-terminal cross-linked telopeptide of type I collagen reflects bone metastasis in hepatocellular carcinoma.
Ueno T; Hashimoto O; Sugawara H; Ogata R; Kusaba N; Torimura T; Sata M; Tanikawa K
Int J Oncol; 1998 Aug; 13(2):297-303. PubMed ID: 9664125
[TBL] [Abstract][Full Text] [Related]
3. Elevated carboxy terminal cross linked telopeptide of type I collagen in alcoholic cirrhosis: relation to liver and kidney function and bone metabolism.
Møller S; Hansen M; Hillingso J; Jensen JE; Henriksen JH
Gut; 1999 Mar; 44(3):417-23. PubMed ID: 10026331
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in chronic liver disease.
Hayasaka A; Iida S; Ohto M
Clin Chim Acta; 1995 Jun; 238(1):85-90. PubMed ID: 7554298
[No Abstract] [Full Text] [Related]
5. Usefulness of serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of bone metastasis from lung cancer.
Horiguchi T; Tachikawa S; Kondo R; Hirose M; Teruya S; Ishibashi A; Banno K
Jpn J Clin Oncol; 2000 Apr; 30(4):174-9. PubMed ID: 10830985
[TBL] [Abstract][Full Text] [Related]
6. Increased serum concentrations of the carboxy-terminal-cross-linked telopeptide of collagen type I in patients with acute Plasmodium falciparum malaria.
Wenisch C; Parschalk B; Schönthal E; Graninger W; Looareesuwan S; Rumpold H
Clin Immunol Immunopathol; 1996 Apr; 79(1):15-9. PubMed ID: 8612346
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis.
Ji X; Li S; Kong X; Xu G; Chen J; Dai X
Chin Med J (Engl); 1997 Mar; 110(3):198-201. PubMed ID: 9594340
[TBL] [Abstract][Full Text] [Related]
8. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
9. Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?
Hunzelmann N; Risteli J; Risteli L; Sacher C; Vancheeswaran R; Black C; Krieg T
Br J Dermatol; 1998 Dec; 139(6):1020-5. PubMed ID: 9990365
[TBL] [Abstract][Full Text] [Related]
10. [Pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen (ICTP)].
Tanaka Y; Kitajima I
Nihon Rinsho; 2004 Dec; 62 Suppl 12():240-3. PubMed ID: 15658309
[No Abstract] [Full Text] [Related]
11. Clinical significance of the serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis.
Fukutomi T; Sakamoto S; Isobe H; Sakai H; Masumoto A; Nawata H
J Gastroenterol Hepatol; 1992; 7(6):596-601. PubMed ID: 1486189
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases.
Hartmann DJ; Trinchet JC; Ricard-Blum S; Beaugrand M; Callard P; Ville G
Clin Chem; 1990 Mar; 36(3):421-6. PubMed ID: 2311207
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
[TBL] [Abstract][Full Text] [Related]
14. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
Kylmälä T; Tammela TL; Risteli L; Risteli J; Kontturi M; Elomaa I
Br J Cancer; 1995 May; 71(5):1061-4. PubMed ID: 7734300
[TBL] [Abstract][Full Text] [Related]
15. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
16. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients.
Reichel H; Roth HJ; Schmidt-Gayk H
Nephron Clin Pract; 2004; 98(4):c112-8. PubMed ID: 15627788
[TBL] [Abstract][Full Text] [Related]
18. Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: a pilot study.
Kato S; Endo I; Fujimura M; Kuriwaka-Kido R; Fujinaka Y; Aihara K; Iwase T; Inoue D; Akaike M; Abe M; Matsumoto T
Atherosclerosis; 2013 Jul; 229(1):182-5. PubMed ID: 23639859
[TBL] [Abstract][Full Text] [Related]
19. Increased type I collagen degradation in early rheumatoid arthritis.
Kotaniemi A; Isomäki H; Hakala M; Risteli L; Risteli J
J Rheumatol; 1994 Sep; 21(9):1593-6. PubMed ID: 7799334
[TBL] [Abstract][Full Text] [Related]
20. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
Elomaa I; Virkkunen P; Risteli L; Risteli J
Br J Cancer; 1992 Aug; 66(2):337-41. PubMed ID: 1503907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
